Platinum-resistant fallopian tube cancer

Clinical trials for Platinum-resistant fallopian tube cancer explained in plain language.

Never miss a new study

Get alerted when new Platinum-resistant fallopian tube cancer trials appear

Sign up with your email to follow new studies for Platinum-resistant fallopian tube cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for Platinum-Resistant ovarian cancer: BD0801 combo trial completed

Disease control Completed

This Phase 3 trial tested whether adding the experimental drug BD0801 to standard chemotherapy can help women with recurrent ovarian cancer that no longer responds to platinum-based treatments. The study enrolled 421 participants and compared the combination to chemotherapy alone…

Matched conditions: PLATINUM-RESISTANT FALLOPIAN TUBE CANCER

Phase 3 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 26, 2026 15:25 UTC

Platinum-resistant fallopian tube cancer

Get alerted when new Platinum-resistant fallopian tube cancer trials appear

New hope for Platinum-Resistant ovarian cancer: BD0801 combo trial completed